Order Article Reprints

Chen J-J, Hsu C-W, Hung C-M, Liang C-S, Su K-P, Carvalho AF, Stubbs B, Chen Y-W, Chen T-Y, Lei W-T, et al. Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors. Pharmaceuticals. 2025; 18(5):735. https://doi.org/10.3390/ph18050735

Chen, Jiann-Jy, Chih-Wei Hsu, Chao-Ming Hung, Chih-Sung Liang, Kuan-Pin Su, Andre F. Carvalho, Brendon Stubbs, Yen-Wen Chen, Tien-Yu Chen, Wei-Te Lei, and et al. 2025. "Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors" Pharmaceuticals 18, no. 5: 735. https://doi.org/10.3390/ph18050735

Chen, J.-J., Hsu, C.-W., Hung, C.-M., Liang, C.-S., Su, K.-P., Carvalho, A. F., Stubbs, B., Chen, Y.-W., Chen, T.-Y., Lei, W.-T., Zeng, B.-Y., & Tseng, P.-T. (2025). Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors. Pharmaceuticals, 18(5), 735. https://doi.org/10.3390/ph18050735